• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Intensive Care Med . Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset

tetano

Editor, Senior Moderator
Intensive Care Med


. 2020 Aug 11;1-9.
doi: 10.1007/s00134-020-06202-3. Online ahead of print.
Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset


Elie Azoulay[SUP] 1 2 [/SUP], Muriel Fartoukh[SUP] 3 4 [/SUP], Michael Darmon[SUP] 5 3 [/SUP], Guillaume G?ri[SUP] 3 6 [/SUP], Guillaume Voiriot[SUP] 3 4 [/SUP], Thibault Dupont[SUP] 5 3 [/SUP], Lara Zafrani[SUP] 5 3 [/SUP], Lola Girodias[SUP] 3 6 [/SUP], Vincent Labb?[SUP] 3 4 [/SUP], Martin Dres[SUP] 3 7 [/SUP], Alexandra Beurton[SUP] 3 7 [/SUP], Antoine Vieillard-Baron[SUP] 3 6 [/SUP], Alexandre Demoule[SUP] 3 7 [/SUP]



Affiliations

Abstract

Purpose: Coronavirus disease 2019 (COVID-19) is creating an unprecedented healthcare crisis. Understanding the determinants of mortality is crucial to optimise intensive care unit (ICU) resource use and to identify targets for improving survival.
Methods: In a multicentre retrospective study, we included 379 COVID-19 patients admitted to four ICUs between 20 February and 24 April 2020 and categorised according to time from disease onset to ICU admission. A Cox proportional-hazards model identified factors associated with 28-day mortality.
Results: Median age was 66 years (53-68) and 292 (77%) were men. The main comorbidities included obesity and overweight (67%), hypertension (49.6%) and diabetes (30.1%). Median time from disease onset (i.e., viral symptoms) to ICU admission was 8 (6-11) days (missing for three); 161 (42.5%) patients were admitted within a week of disease onset, 173 (45.6%) between 8 and 14 days, and 42 (11.1%) > 14 days after disease onset; day 28 mortality was 26.4% (22-31) and decreased as time from disease onset to ICU admission increased, from 37 to 21% and 12%, respectively. Patients admitted within the first week had higher SOFA scores, more often had thrombocytopenia or acute kidney injury, had more limited radiographic involvement, and had significantly higher blood IL-6 levels. Age, COPD, immunocompromised status, time from disease onset, troponin concentration, and acute kidney injury were independently associated with mortality.
Conclusion: The excess mortality in patients admitted within a week of disease onset reflected greater non-respiratory severity. Therapeutic interventions against SARS-CoV-2 might impact different clinical endpoints according to time since disease onset.

Keywords: Acute kidney injury; Acute respiratory distress syndrome; Coronavirus; Viral infection.
 
Back
Top Bottom